Recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798 Conditions Adnexal Diseases, Advance Solid Tumors, Biliary Cancers, +37 more Locations Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Completed A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer NCT02352948 Conditions Non - Small Cell Lung Cancer NSCLC Locations Research Site — Chandler, Arizona, United States Research Site — Anaheim, California, United States Research Site — Duarte, California, United States Research Site — La Jolla, California, United States View all 201 locations View more locations Show fewer locations Loading locations... View Trial Details
